Sequential treatment with vindesine–ifosfamide–platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A phase II trial1Data presented in part at the 61st Annual International Scientific (Q61866254)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 1998

Language	Label	Description	Also known as
English	Sequential treatment with vindesine–ifosfamide–platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A phase II trial1Data presented in part at the 61st Annual International Scientific	scientific article published in October 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

author name string

P Van den Brande

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D De Ruysscher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J Vansteenkiste

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Specenier

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Demedts

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P Spaas

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

45-53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Non-small-cell lung carcinoma. Current and future therapeutic management

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review. The Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of pulmonary function in patients receiving mitomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of irradiation on lung function and perfusion in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Science, medicine, and the future. Lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation for non-small cell lung cancer using conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900071-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(98)00071-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9869107%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61866254&oldid=2168180123"